Viatris (VTRS) Selling, General & Administrative (2020 - 2026)
Powered by 
Analysis
Viatris (VTRS) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.64 Bn | 38.98 Bn | 2.15 Bn | 317.00 Mn |
| 2 | Viatris | 19.19 Bn | 18.30 Bn | 1.46 Bn | 1.13 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.68 Bn | 396.53 Mn | 304.42 Mn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | 148.72 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 526.00 Mn | 2.10 Bn | 907.00 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -43.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 91.66 Mn |
| 8 | Amphastar Pharmaceuticals | 995.08 Mn | 704.96 Mn | 93.47 Mn | 18.24 Mn |
| 9 | Fennec Pharmaceuticals | 406.25 Mn | 365.00 Mn | 17.15 Mn | 4.64 Mn |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.13 Bn |
| Mar 31, 2026 | 928.80 Mn |
| Dec 31, 2025 | 1.03 Bn |
| Sep 30, 2025 | 886.60 Mn |
| Jun 30, 2025 | 928.70 Mn |
| Mar 31, 2025 | 948.10 Mn |
| Dec 31, 2024 | 1.05 Bn |
| Sep 30, 2024 | 1.00 Bn |
| Jun 30, 2024 | 1.04 Bn |
| Mar 31, 2024 | 1.02 Bn |
| Dec 31, 2023 | 1.03 Bn |
| Sep 30, 2023 | 1.05 Bn |
| Jun 30, 2023 | 1.03 Bn |
| Mar 31, 2023 | 958.90 Mn |
| Dec 31, 2022 | 1.27 Bn |
| Sep 30, 2022 | 1.02 Bn |
| Jun 30, 2022 | 981.10 Mn |
| Mar 31, 2022 | 915.30 Mn |
| Dec 31, 2021 | 1.08 Bn |
| Sep 30, 2021 | 1.06 Bn |